Saffron Total-glycoside Tablet group:Saffron Total-glycoside Tablet (Approval No. Z20163079) 4 tablets/time, 3 times/day for 6 months

2 trials

Sponsors

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine

Conditions

Breast Cancer, Heart Failure, Cardiotoxicity

Phase 4

Cardioprotective effect of Saffron Total-glycoside Tablet in patients with breast cancer receiving anthracycline-based chemotherapy: a multicenter, randomized, parallel, double-blind placebo clinical trial

Active, not recruitingITMCTR2100004507

Guang'anmen Hospital, Chinese Academy of traditional Chinese MedicineBreast Cancer, Heart Failure, Cardiotoxicity

Start: 2021-06-01Updated: 2023-02-20

Cardioprotective effect of Saffron Total-glycoside Tablet in patients with breast cancer receiving anthracycline-based chemotherapy: a multicenter, randomized, parallel, double-blind placebo clinical trial

Active, not recruitingChiCTR2000041134

Guang'anmen Hospital, Chinese Academy of traditional Chinese MedicineBreast Cancer, Heart Failure, Cardiotoxicity

Start: 2021-06-01Updated: 2021-03-01

Related Papers

Cardioprotective effect of crocin in patients with breast cancer receiving anthracycline-based chemotherapy: A randomized, double-blind, placebo-controlled study

Pharmacological Research2025-01-303 citations

Cardioprotective effect of saffron total glycoside tablets in patients with breast cancer receiving anthracycline-based chemotherapy: study protocol for a multicentre, randomised, parallel, double-blind, placebo-controlled clinical trial

Annals of Palliative Medicine2021-06-298 citations